Real Money Latest Headlines

James Rev Shark DePorre

Bears Are Giving Up on the 'Trade War Will Kill the Market' Theme

By

James "Rev Shark" DePorre

|
Sep 19, 2018 | 8:18 AM EDT
Tony Owusu

LIVE MARKETS BLOG

By

Tony Owusu

|
Sep 19, 2018 | 8:07 AM EDT
Stephen Guilfoyle

How to Play Ailing Micron Technology on This Drop: Market Recon

By

Stephen Guilfoyle

|
Sep 19, 2018 | 7:49 AM EDT
Maleeha Bengali

Dollar Falls and Market Rallies on Tariffs: What Gives?

By

Maleeha Bengali

|
Sep 19, 2018 | 6:08 AM EDT
Helene Meisler

How Is It Possible That Sentiment for Bonds Barely Budged?

By

Helene Meisler

|
Sep 19, 2018 | 6:00 AM EDT
Kevin Curran

FedEx Tanks After It Fails to Deliver on Earnings

By

Kevin Curran

|
Sep 18, 2018 | 5:56 PM EDT
Kevin Curran

FedEx's Free Cash Flow Offers a Positive Signal for a Sagging Stock

By

Kevin Curran

|
Sep 18, 2018 | 5:29 PM EDT
Tony Owusu

RMPIA Facebook, Banks Went Back and Forth Over User Data: LIVE MARKETS BLOG

By

Tony Owusu

|
Sep 18, 2018 | 4:29 PM EDT
James Rev Shark DePorre

RMPIA Today's Market Was Primarily Fueled by Bad Positioning

By

James "Rev Shark" DePorre

|
Sep 18, 2018 | 4:24 PM EDT
Kevin Curran

Chart of the Day: How Tariff Talk Hurts FedEx Stock

By

Kevin Curran

|
Sep 18, 2018 | 3:43 PM EDT
Christopher Versace

RMPIA Investors Should View the Pullback in FedEx as an Opportunity for What's Ahead

By

Christopher Versace

|
Sep 18, 2018 | 3:30 PM EDT
Kevin Curran

Experts Are High on Cannabis Stocks' 2019 Prospects

By

Kevin Curran

|
Sep 18, 2018 | 3:06 PM EDT
See More Headlines

Upgrades & Downgrades

WMT
Update
Walmart Rated New Outperform at BMO
Sep 18, 2018 | 8:19 AM EDT
Walmart was initiated with an "outperform" rating at BMO with a $110 price target.
RIG
Update
Transocean Rated New Buy at BTIG
Sep 18, 2018 | 8:19 AM EDT
Transocean initiated with a "buy" rating at BTIG with an $18 price target.
DISCA
Bearish
Discovery Downgraded to SEll at Pivotal Research
Sep 18, 2018 | 8:17 AM EDT
Discovery was downgraded to "sell" at Pivotal Research with a $26 price target.
ARRY
Update
Array BioPharma Rated New Buy at Guggenheim
Sep 18, 2018 | 8:17 AM EDT
Array BioPharma was initiated with a "buy" rating and $32 price target at Guggenheim.
APA
Update
Apache Rated New Overweight at Stephens
Sep 18, 2018 | 8:16 AM EDT
Apache was initiated with an "overweight" rating at Stephens with a $52 price target.
See More »

Columnist Conversations

Kevin Curran:
Shorts Might Need Some Medicine
Tilray's staggering 41% rise this morning leaves the company with an insane valuation and leaves Canopy Growth...
Brian Sozzi:
Cannabis Craziness
I badly want to be the person that calls the top in red-hot cannabis stocks, but fear looking like a short-ter...
Brian Sozzi:
On Tesla....
Now the government will get to really dive into the inner workings of Tesla (TSLA) . Who knows what else they...
Carolyn Boroden:
GS Daily
In GS I see key price support at the 224.49-226.42 area.  I also have timing for a possible low.  I ...
See all »
RMPIA
RMPIA TODAY
RMPIA Year-to-Date:
SEE COMPONENTS »

REAL MONEY'S BEST IDEAS

SEE MORE»

News Breaks

Powered by
See More ยป

COLUMNIST TWEETS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.
Compare Brokers